Panama Petrochem (PANAMAPET)
Slow GrowerFairStock Score: 51/100 — MIXED
Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹482.6 |
| Market Cap | ₹2,919.42 Cr |
| P/E Ratio | 13.74 |
| ROCE | 20.41% |
| ROE | 15.6% |
| Dividend Yield | 0.55% |
| Profit Growth | 60.5% |
| Debt/Equity | 0.08 |
| Sales Growth | 18.3% |
| Promoter Holding | 63.16% |
| 52-Week Range | ₹229 — ₹599.6 |
| Sector | Petroleum Products |
| Book Value | ₹242.78 |
Strengths
- Negligible debt (D/E 0.02) with strong ROCE of 20.41%
- Promoter holding at 63.16% aligns owner interests
- Reasonable valuation at P/E 9.17 and P/B 1.87
- Dividend yield of 1.78% offers some income support
Concerns
- Profit fell 5.55% despite sales growth of 6.47%, indicating margin pressure
- Piotroski F-Score of 4/9 suggests weak fundamental health
- Stock is far below its 52-week high of ₹599.60, showing volatility
- PEG of 1.42 with negative profit growth is not compelling
AI Analysis
Panama Petrochem is a lubricants business, and I can understand that. But understanding must be followed by numbers. The company has a clean balance sheet: debt/equity 0.02, ROCE 20.41%, ROE 14.14%. That is respectable. Promoter holding 63.16% gives me comfort that owners are aligned. At ₹273.58, the stock trades at 9.17 times earnings and 1.87 times book value, with a 1.78% dividend yield. That is not an absurd price. However, I am not buying today. Sales grew 6.47%, but profit fell 5.55%. A business whose costs grow faster than revenue does not meet my test of consistent earning power. The Piotroski F-score is 4 out of 9, which is weak and points to deteriorating fundamentals. The 52-week range of ₹229 to ₹599.60 tells me Mr. Market has been emotional; the current price is near the bottom, but a low price alone is not a margin of safety. The PEG ratio of 1.42 with negligible profit growth suggests there is no cheap growth here. I would classify this as a slow grower. The low debt and good return on capital are real strengths, but I need evidence that margins and profits can stabilise before I commit capital. If the company can turn sales growth into profit growth while keeping leverage low, the current valuation may look interesting. For now, I prefer to wait and watch. As Graham said, price is what you pay, value is what you get. I need more clarity on the value.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer